AssetMark Inc’s Evolent Health EVH Stock Holding History

AssetMark Inc’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-150	Closed	-$4.96K	–	1988
2023 Q4	$4.96K	Buy	+150	New	+$4.24K	﹤0.01%	1448

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

AssetMark Inc's EVH Position: Q1 2024 in Review

AssetMark Inc sold out of Evolent Health (EVH) in Q1 2024, closing a stake of 150 shares — an estimated $4.96K sold.

AssetMark Inc first reported a position in EVH in Q4 2023 and held it in 1 quarter. The position peaked at $4.96K in Q4 2023. 251 funds tracked by Wall St. Rank hold EVH as of Q1 2024.

AssetMark Inc reported no remaining Evolent Health position as of Q1 2024 after selling out during the quarter.
AssetMark Inc sold 150 Evolent Health shares in Q1 2024, an estimated $4.96K.
AssetMark Inc first reported a position in Evolent Health in Q4 2023 and held it in 1 quarter.
AssetMark Inc's Evolent Health position peaked at $4.96K in Q4 2023.
251 funds tracked by Wall St. Rank held Evolent Health as of Q1 2024.

Based on AssetMark Inc's 13F filing for Q1 2024, filed 7 May 2024.